Skip to main content
Equibles

STATE STREET CORP

Position in LITS — Lite Strategy, Inc.

CIK 93751 BOSTON, MA
Back to LITS Full portfolio

Position in LITS

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$105,819
-$27,605 QoQ
Shares Held
115,021
0.0% QoQ
Ownership
0.378%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 35 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in LITS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. LITS ranks #378 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in LITS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $105,819 115,021
2026-03-31 $133,424 115,021
2025-12-31 $151,827 115,021
2025-09-30 $278,350 115,021
2025-06-30 $44,017 17,821
2025-03-31 $39,027 17,821
2024-12-31 $43,839 17,821
2024-09-30 $50,789 17,821
2024-06-30 $51,859 17,821
2024-03-31 $71,284 17,821
2023-12-31 $103,361 17,821
2023-09-30 $124,925 17,821
2023-06-30 $117,262 17,821